Logo image of MAMA

MAMA'S CREATIONS INC (MAMA) Stock Fundamental Analysis

NASDAQ:MAMA - Nasdaq - US56146T1034 - Common Stock - Currency: USD

8.19  +0.14 (+1.74%)

After market: 8.19 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MAMA. MAMA was compared to 91 industry peers in the Food Products industry. MAMA has an average financial health and profitability rating. MAMA is valued quite expensively, but it does show have an excellent growth rating. These ratings would make MAMA suitable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MAMA had positive earnings in the past year.
In the past year MAMA had a positive cash flow from operations.
Of the past 5 years MAMA 4 years were profitable.
Each year in the past 5 years MAMA had a positive operating cash flow.
MAMA Yearly Net Income VS EBIT VS OCF VS FCFMAMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

1.2 Ratios

MAMA's Return On Assets of 8.34% is amongst the best of the industry. MAMA outperforms 85.71% of its industry peers.
MAMA's Return On Equity of 16.62% is amongst the best of the industry. MAMA outperforms 85.71% of its industry peers.
Looking at the Return On Invested Capital, with a value of 12.98%, MAMA belongs to the top of the industry, outperforming 91.21% of the companies in the same industry.
Industry RankSector Rank
ROA 8.34%
ROE 16.62%
ROIC 12.98%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAMA Yearly ROA, ROE, ROICMAMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

The Profit Margin of MAMA (3.41%) is better than 62.64% of its industry peers.
MAMA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 4.41%, MAMA is in line with its industry, outperforming 54.95% of the companies in the same industry.
MAMA's Operating Margin has declined in the last couple of years.
MAMA has a Gross Margin of 24.39%. This is comparable to the rest of the industry: MAMA outperforms 57.14% of its industry peers.
MAMA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.41%
PM (TTM) 3.41%
GM 24.39%
OM growth 3Y185.5%
OM growth 5Y-8.49%
PM growth 3YN/A
PM growth 5Y-7.87%
GM growth 3Y0.31%
GM growth 5Y-3.01%
MAMA Yearly Profit, Operating, Gross MarginsMAMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MAMA is still creating some value.
MAMA has more shares outstanding than it did 5 years ago.
MAMA Yearly Shares OutstandingMAMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M
MAMA Yearly Total Debt VS Total AssetsMAMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 9.87 indicates that MAMA is not in any danger for bankruptcy at the moment.
The Altman-Z score of MAMA (9.87) is better than 93.41% of its industry peers.
MAMA has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
MAMA's Debt to FCF ratio of 1.99 is amongst the best of the industry. MAMA outperforms 84.62% of its industry peers.
MAMA has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.07, MAMA is doing good in the industry, outperforming 73.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.99
Altman-Z 9.87
ROIC/WACC1.46
WACC8.87%
MAMA Yearly LT Debt VS Equity VS FCFMAMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

MAMA has a Current Ratio of 1.29. This is a normal value and indicates that MAMA is financially healthy and should not expect problems in meeting its short term obligations.
MAMA has a Current ratio of 1.29. This is in the lower half of the industry: MAMA underperforms 62.64% of its industry peers.
MAMA has a Quick Ratio of 1.01. This is a normal value and indicates that MAMA is financially healthy and should not expect problems in meeting its short term obligations.
MAMA has a Quick ratio of 1.01. This is in the better half of the industry: MAMA outperforms 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.01
MAMA Yearly Current Assets VS Current LiabilitesMAMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 5M 10M 15M 20M

7

3. Growth

3.1 Past

MAMA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.67%.
The Earnings Per Share has been growing by 17.61% on average over the past years. This is quite good.
MAMA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.04%.
Measured over the past years, MAMA shows a very strong growth in Revenue. The Revenue has been growing by 29.59% on average per year.
EPS 1Y (TTM)-26.67%
EPS 3YN/A
EPS 5Y17.61%
EPS Q2Q%200%
Revenue 1Y (TTM)17.04%
Revenue growth 3Y37.85%
Revenue growth 5Y29.59%
Sales Q2Q%18.15%

3.2 Future

Based on estimates for the next years, MAMA will show a very strong growth in Earnings Per Share. The EPS will grow by 68.33% on average per year.
The Revenue is expected to grow by 13.60% on average over the next years. This is quite good.
EPS Next Y85.11%
EPS Next 2Y68.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.36%
Revenue Next 2Y13.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MAMA Yearly Revenue VS EstimatesMAMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
MAMA Yearly EPS VS EstimatesMAMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 74.45, which means the current valuation is very expensive for MAMA.
MAMA's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.99, MAMA is valued quite expensively.
The Price/Forward Earnings ratio is 32.12, which means the current valuation is very expensive for MAMA.
The rest of the industry has a similar Price/Forward Earnings ratio as MAMA.
When comparing the Price/Forward Earnings ratio of MAMA to the average of the S&P500 Index (36.36), we can say MAMA is valued inline with the index average.
Industry RankSector Rank
PE 74.45
Fwd PE 32.12
MAMA Price Earnings VS Forward Price EarningsMAMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

63.74% of the companies in the same industry are cheaper than MAMA, based on the Enterprise Value to EBITDA ratio.
MAMA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 100.96
EV/EBITDA 32.73
MAMA Per share dataMAMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

MAMA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MAMA's earnings are expected to grow with 68.33% in the coming years.
PEG (NY)0.87
PEG (5Y)4.23
EPS Next 2Y68.33%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MAMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAMA'S CREATIONS INC

NASDAQ:MAMA (8/6/2025, 8:00:00 PM)

After market: 8.19 0 (0%)

8.19

+0.14 (+1.74%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)06-03 2025-06-03/amc
Earnings (Next)09-08 2025-09-08
Inst Owners74.04%
Inst Owner ChangeN/A
Ins Owners4.3%
Ins Owner Change3.6%
Market Cap308.03M
Analysts82
Price Target10.54 (28.69%)
Short Float %5.53%
Short Ratio6.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.78%
Min EPS beat(2)6.95%
Max EPS beat(2)42.6%
EPS beat(4)3
Avg EPS beat(4)-1.66%
Min EPS beat(4)-73.86%
Max EPS beat(4)42.6%
EPS beat(8)6
Avg EPS beat(8)12.27%
EPS beat(12)9
Avg EPS beat(12)51.43%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.86%
Min Revenue beat(2)5.57%
Max Revenue beat(2)6.15%
Revenue beat(4)3
Avg Revenue beat(4)3.36%
Min Revenue beat(4)-1.14%
Max Revenue beat(4)6.15%
Revenue beat(8)7
Avg Revenue beat(8)4.77%
Revenue beat(12)10
Avg Revenue beat(12)3.93%
Revenue beat(16)13
Avg Revenue beat(16)3.25%
PT rev (1m)0%
PT rev (3m)-6.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.21%
Valuation
Industry RankSector Rank
PE 74.45
Fwd PE 32.12
P/S 2.39
P/FCF 100.96
P/OCF 40.85
P/B 11.65
P/tB 20.9
EV/EBITDA 32.73
EPS(TTM)0.11
EY1.34%
EPS(NY)0.26
Fwd EY3.11%
FCF(TTM)0.08
FCFY0.99%
OCF(TTM)0.2
OCFY2.45%
SpS3.42
BVpS0.7
TBVpS0.39
PEG (NY)0.87
PEG (5Y)4.23
Profitability
Industry RankSector Rank
ROA 8.34%
ROE 16.62%
ROCE 16.71%
ROIC 12.98%
ROICexc 20.07%
ROICexgc 42.87%
OM 4.41%
PM (TTM) 3.41%
GM 24.39%
FCFM 2.37%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y219.36%
ROICexcg growth 5Y-6.93%
ROICexc growth 3Y244.9%
ROICexc growth 5Y-16.03%
OM growth 3Y185.5%
OM growth 5Y-8.49%
PM growth 3YN/A
PM growth 5Y-7.87%
GM growth 3Y0.31%
GM growth 5Y-3.01%
F-Score5
Asset Turnover2.44
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.99
Debt/EBITDA 0.22
Cap/Depr 132.57%
Cap/Sales 3.49%
Interest Coverage 14.38
Cash Conversion 83.15%
Profit Quality 69.42%
Current Ratio 1.29
Quick Ratio 1.01
Altman-Z 9.87
F-Score5
WACC8.87%
ROIC/WACC1.46
Cap/Depr(3y)80.56%
Cap/Depr(5y)82.95%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.69%
Profit Quality(3y)128.45%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.67%
EPS 3YN/A
EPS 5Y17.61%
EPS Q2Q%200%
EPS Next Y85.11%
EPS Next 2Y68.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.04%
Revenue growth 3Y37.85%
Revenue growth 5Y29.59%
Sales Q2Q%18.15%
Revenue Next Year17.36%
Revenue Next 2Y13.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.45%
EBIT growth 3Y293.57%
EBIT growth 5Y18.58%
EBIT Next Year200.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.33%
FCF growth 3Y17.93%
FCF growth 5Y-44.38%
OCF growth 1Y-10.86%
OCF growth 3Y78.52%
OCF growth 5Y23.39%